Skip to content

The effect of Magnesium sulphate on increased intra ocular pressure due to general anesthesia

The effect of intravenous magnesium sulfate on intraocular pressure changes following tracheal intubation in adults in Shiraz University affiliated hospital

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138812013376N1
Enrollment
180
Registered
2011-02-16
Start date
2007-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persons encountering health services for specific procedures and health care. Persons encountering health services for specific procedures and health care

Interventions

Intervention 1: administration of magnesium sulphate once 30mg/kg IV before induction of Anesthesia. Intervention 2: administration of normal saline once 30mg/kg IV before induction of Anesthesia.
Prevention
Placebo
administration of magnesium sulphate once 30mg/kg IV before induction of Anesthesia
administration of normal saline once 30mg/kg IV before induction of Anesthesia

Sponsors

Vice Chancellor for Research of Shiraz University of Medical Science,Anesthesia department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 180 patients (ASA I) healthy adult, (18 to 38years old, both man and woman) that were scheduled for elective non ocular surgery (ENT and ambulatory surgery that needed tracheal intubation), were selected. exclusion criteria: The patients with specific major hepatic, renal and cardio-vascular disease as well as those known to have allergic reaction to magnesium sulphate or other drugs on basis of the history of patients, and hypermagnesemia, hypocalcemia on the basis on lab data, anuria, heart block (ECG), pregnancy, any degree of renal insufficiency, digitalised patients, positive history of glaucoma, or intra ocular hypertension, and patients who refused to participate in this study, were excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Iop (Intra ocular pressure). Timepoint: In 4 stage (T1:Before induction of anesthesia ,T2 :Just before intubation , T3:1 minute after intubation ,T4:5 minute after intubation. Method of measurement: TONOPEN Instrument.

Secondary

MeasureTime frame
Systolic BP. Timepoint: 4 stages ; T1 :Before Induction of anesthesia , T2 : just before intubation ,T3 : 1 minute after intubation, T4 :5 minute after intubation. Method of measurement: NIBP monitoring.;Diastolic BP. Timepoint: 4 stages ; T1 :Before Induction of anesthesia , T2 : just before intubation ,T3 : 1 minute after intubation, T4 :5 minute after intubation. Method of measurement: NIBP monitoring.;Mean Arterial Pressure. Timepoint: 4 stages ; T1 :Before Induction of anesthesia , T2 : just before intubation ,T3 : 1 minute after intubation, T4 :5 minute after intubation. Method of measurement: NIBP monitoring.;Heart Rate. Timepoint: 4 stages ; T1 :Before Induction of anesthesia , T2 : just before intubation ,T3 : 1 minute after intubation, T4 :5 minute after intubation. Method of measurement: EKG monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sina Ghaffari pour

Shiraz Universityof Medical Science

sina50@gmail.com+98 71 1233 7636

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026